Source: BioPortfolio

CaroGen: Prominent Immunologists Join CaroGens Scientific Advisory Board to Expand and Expedite Immuno Oncology Pipeline

Eminent new board members bring experience and deep expertise to Connecticut biotech companyFARMINGTON Conn. PRWEB October 28 2019 CaroGen Corporation a biotechnology company today announced three distinguished additions to its Scientific Advisory Board ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Bijan Almassian's photo - President & CEO of CaroGen

President & CEO

Bijan Almassian

CEO Approval Rating

83/100

Read more